Cargando…
Repurposing Siddha mercurial drug for mild to moderate COVID-19 – Case series and exploration of its chemical profile
Vajra kandi maathirai (VKM) is a mercury-based traditional Siddha drug used to treat various types of fevers and inflammatory diseases. We report our experience of using VKM successfully in the treatment of 5 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients along with i...
Autores principales: | Shiva, Saravana, Mari, Shanmugam, Amuthan, Arul, Shanmugam, Ramalingam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241656/ https://www.ncbi.nlm.nih.gov/pubmed/34226805 http://dx.doi.org/10.1016/j.jaim.2021.06.009 |
Ejemplares similares
-
STANDARDISATION STUDIES ON SOME MERCURIALS OF SIDDHA SYSTEM(*)
por: Saraswathy, A., et al.
Publicado: (1993) -
Safety and efficacy of siddha medicine preparation in the management of COVID-19: A prospective randomised open label study
por: Shanmugam, K., et al.
Publicado: (2022) -
STANDARDISATION OF SIDDHA DRUGS
por: Saraswathy, Ariamuthu
Publicado: (1994) -
Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals
por: N, Kannan, et al.
Publicado: (2018) -
Correction: Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals
por: Kannan, N, et al.
Publicado: (2018)